ARCHIVES

Three Institutes To Test BioMicro’s Microarray Product. GlycoDesign Allowed Patent For Cancer Drug GD0039.

This article is from The Cancer Letter archive.

Vol. 28 No. 09 | March 1, 2002

Download PDF Visit The Full Archive

Related Articles

NCA Members To Hear PDQ Issue, Reports On AIDs, Lung Cancer, Cell Invasiveness, Smoking Program, Small Business Grants

September 30, 1983

FDA Breakthrough Designation Granted to Pfizer’s Palbociclib

April 26, 2013

DCT Board Approves Concept of New Programs, Including “Task Order”

November 2, 1979

NCI Study Says 2 Million US Women Could Benefit from Tamoxifen

April 11, 2003

M.D. Anderson, SWOG To Use Web-Based Software To Expand Access To Trials.

September 29, 2000

Patient Advocacy: Prostate Cancer Agenda Didn’t Include NCI Plans, Lausner Says

November 29, 1996